Aspergillosis Clinical Trials Aspergillosis RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Olorofim Aspergillus Infection Study
Condition:   Invasive Aspergillosis Interventions:   Drug: Olorofim;   Drug: AmBisome® Sponsors:   F2G Biotech GmbH;   Iqvia Pty Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2021 Category: Research Source Type: clinical trials